Related Experiment Video
Updated: Jun 30, 2026

09:18
Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
Three-dimensional context regulation of metastasis
Janine T Erler1, Valerie M Weaver
1Hypoxia and Metastasis Team, Section of Cell and Molecular Biology, The Institute of Cancer Research, London, UK. Janine.erler@icr.ac.uk
Clinical & Experimental Metastasis
|September 25, 2008
Summary
Tumor progression and metastasis are driven by the tumor microenvironment, specifically extracellular matrix (ECM) remodeling and hypoxia. These factors synergistically promote cancer growth, invasion, and spread, highlighting potential therapeutic targets.
Area of Science:
- Oncology
- Cancer Biology
- Biochemistry
Background:
- Tumor progression occurs within a complex three-dimensional microenvironment.
- Non-cellular components like the extracellular matrix (ECM) and hypoxia significantly influence cancer metastasis.
- ECM remodeling and hypoxia are key factors in tumor growth, invasion, and dissemination.
Purpose of the Study:
- To investigate the synergistic interactions between ECM remodeling and tumor hypoxia in promoting tumor progression.
- To elucidate the molecular pathways through which these microenvironmental factors drive metastasis.
- To identify novel therapeutic targets for cancer treatment.
Main Methods:
- Review and synthesis of existing literature on ECM remodeling and tumor hypoxia.
- Analysis of molecular mechanisms linking ECM changes and hypoxic conditions to cancer progression.
- Identification of common pathways influenced by both factors.
Main Results:
- ECM remodeling, including collagen cross-linking and matrix degradation, stiffens the tumor stroma, promoting cancer cell transformation, growth, motility, and invasion.
- Tumor hypoxia induces pro-migratory and pro-invasion genes, enhances cancer cell survival, and upregulates ECM components and modifying enzymes.
- Synergistic interactions between ECM remodeling and hypoxia converge on common mechanisms that enhance tumor progression and metastasis.
Conclusions:
- ECM remodeling and tumor hypoxia are critical non-cellular components that cooperatively drive tumor progression and metastasis.
- Understanding the intersecting molecular pathways is crucial for developing effective therapeutic strategies.
- Targeting the interplay between ECM remodeling and hypoxia holds promise for novel cancer therapies.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

